Welcome to our dedicated page for Charlottes Web news (Ticker: CWBHF), a resource for investors and traders seeking the latest updates and insights on Charlottes Web stock.
Charlotte's Web Holdings, Inc. (CWBHF) generates frequent news as a botanical wellness innovation company and market leader in hemp extract wellness and hemp-derived CBD wellness products. Headquartered in Louisville, Colorado and listed on the Toronto Stock Exchange under the symbol CWEB, the company issues regular updates on product launches, operational developments, financial results, and regulatory engagement.
News about Charlotte's Web often highlights new product introductions across CBD oil tinctures, CBD gummies, CBN and CBG gummies, hemp-derived THC microdose gummies, Brightside hemp-derived THC gummies, functional mushroom gummies, and CBD pet products for dogs. Recent announcements include the launch of Quiet Sleep Mushroom Gummies, a melatonin-free and cannabinoid-free sleep support product, and Knockout hemp THC sleep gummies under the Brightside brand, which use a rapid-onset delivery technology.
Investors and followers can also expect coverage of the company's financial performance through quarterly earnings releases, where Charlotte's Web discusses revenue trends, cost structure initiatives, and manufacturing internalization, particularly for gummy production. Additional news items describe the formation of a Scientific Advisory Board, expansion of the medical channel strategy, and participation in a Medicare and Medicaid Innovation pilot program to provide CBD options for senior oncology patients.
Regulatory and policy developments are another recurring theme. Charlotte's Web reports on federal and state-level hemp and CBD regulation, its involvement in industry coalitions such as ONE HEMP, and its perspective on proposed THC limits for hemp-derived products. Updates related to DeFloria, Inc., the Phase 2 clinical-stage botanical pharmaceutical company formed with AJNA BioSciences PBC and supported by a subsidiary of British American Tobacco plc, also appear in the news, including progress on AJA001 oral solution for irritability associated with autism spectrum disorder.
For investors, analysts, and consumers, the Charlotte's Web news feed provides ongoing insight into the company's product pipeline, strategic priorities, regulatory environment, and role in the evolving hemp and botanical wellness market.
Charlotte's Web Holdings has entered into an Option Purchase Agreement with Stanley Brothers USA, a cannabis wellness incubator, allowing Charlotte's Web to acquire the company within five years, contingent upon certain conditions. Stanley Brothers operates in Colorado, California, and Florida and plans to expand into eight more states. The agreement involves a purchase price determined by revenue and EBITDA multiples. The Option was purchased for US$8 million. Charlotte's Web aims to strengthen its presence in the cannabis wellness market as consumer trends and laws evolve favorably.
Charlotte's Web Holdings, Inc. (CWBHF) has announced a collaboration with McLean Hospital and Harvard Medical School's Dr. Staci Gruber to conduct two clinical trials examining the efficacy of a custom-formulated, high-CBD product. Funded by CW Labs, results are expected to be published in 2022. Dr. Gruber's MIND program aims to study the long-term impact of cannabis on health. This partnership reflects Charlotte's Web's commitment to supporting third-party research in the hemp CBD sector.
Charlotte's Web Holdings, Inc. (CWBHF) has achieved B Corporation™ certification, underscoring its commitment to social and environmental performance. This certification aligns with the company's mission to benefit stakeholders, including customers and communities. Joining over 3,500 certified B Corps worldwide, Charlotte's Web formalizes its dedication to sustainability and accountability. CEO Deanie Elsner emphasized this milestone as a means to enhance their business practices from seed to shelf, promoting better outcomes for society and the environment.